1. X
  2. InvestorsHub
Log inSign up
InvestorsHub
16K posts
user avatar
InvestorsHub
@Investors_Hub
Investor community for traders & active investors. Real-time market discussion, stock boards, trading ideas, breaking news & trending stocks.
In front of our real time data
investorshub.advfn.com
Joined January 2010
308
Following
4,172
Followers
RepliesRepliesMediaMedia

Log in or sign up for X

See what’s happening and join the conversation

Continue with phone
or
Log in with username or email
Terms·Privacy·Cookies·Accessibility·Ads Info·© 2026 X Corp.
  • user avatar
    InvestorsHub
    @Investors_Hub
    Jul 30
    VSee Health Signs LOI for Healthcare Platform Acquisition Target With Over $35 Million in Annualized Revenue
    investorshub.advfn.com
    VSee Health Signs LOI for Healthcare Platform Acquisition Target With Over $35 Million in Annuali...
    VSee Health (NASDAQ:VSEE) signed an LOI to acquire healthcare commerce platform assets that generate more than $35 million in annualized revenue and approximately $7 million in EBITDA.
    126
  • user avatar
    InvestorsHub
    @Investors_Hub
    Jul 30
    Black Dragon Resource Company Signs Sand Plant LOI to Support Texas Production Plans
    investorshub.advfn.com
    Black Dragon Resource Company Signs Sand Plant LOI to Support Texas Production Plans
    Black Dragon Resource Company (USOTC:BDGR) signed an LOI to acquire a Texas sand processing plant, aiming to begin production and generate revenue within months.
    89
  • user avatar
    InvestorsHub
    @Investors_Hub
    Jul 30
    Netlist Reports Strong Q2 2026 Results as Revenue Surges 163% and Company Returns to Profitability
    investorshub.advfn.com
    Netlist Reports Strong Q2 2026 Results as Revenue Surges 163% and Company Returns to Profitability
    Netlist (OTCQB:NLST) reported strong Q2 2026 results with 163% revenue growth, a return to profitability, and continued investment in AI memory technologies.
    111
  • user avatar
    InvestorsHub
    @Investors_Hub
    Jul 30
    Anavex Life Sciences Reports Preliminary Q2 2026 Results and Advances FDA Strategy for Blarcamesine
    investorshub.advfn.com
    Anavex Life Sciences Reports Preliminary Q2 2026 Results and Advances FDA Strategy for Blarcamesine
    Anavex Life Sciences (NASDAQ:AVXL) reported preliminary Q2 2026 results, outlined its FDA strategy for blarcamesine, and said its cash runway extends into fiscal 2028.
    88
  • user avatar
    InvestorsHub
    @Investors_Hub
    Jul 30
    Columbus McKinnon Reports Record Q1 FY27 Orders and Sales, Raises Full-Year Guidance
    investorshub.advfn.com
    Columbus McKinnon Reports Record Q1 FY27 Orders and Sales, Raises Full-Year Guidance
    Columbus McKinnon (NASDAQ:CMCO) reported record first-quarter FY27 orders and sales, raised full-year guidance, and highlighted continued progress integrating Kito Crosby.
    82